| Online: | |
| Visits: | |
| Stories: |
| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Johnson & Johnson Appoints New Director
New Brunswick, N.J. (June 9, 2015) – Johnson & Johnson (NYSE:JNJ) announced today that its Board of Directors has appointed Mary Beckerle, Ph.D., Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah, as a Director of Johnson & Johnson. Dr. Beckerle will serve on the Board’s Science, Technology & Sustainability Committee.
Dr. Beckerle has served as CEO and Director of Huntsman Cancer Institute since 2006, and she was appointed in 2009 to an additional key health sciences leadership role as Associate Vice President for Cancer Affairs at the University of Utah. She joined the faculty of the University of Utah in 1986, and is a distinguished professor of biology and oncological sciences, holding the Ralph E. and Willia T. Main Presidential Professorship.
“Dr. Beckerle’s expertise in scientific research and organizational management in the health care arena will be invaluable as a member of our Board of Directors,” said Alex Gorsky, Chairman and CEO of Johnson & Johnson. “Her commitment to the needs of patients is directly aligned with Our Credo and mission, and she is a welcome addition to the Johnson & Johnson Board.”
As an active participant in national and international scientific affairs, Dr. Beckerle has served on the NIH Advisory Committee to the Director and as the Chair of the American Cancer Society Council for Extramural Grants. She currently serves on the Scientific Review Board of the Howard Hughes Medical Institute and the Scientific Advisory Boards of the National Center for Biological Sciences at the Tata Institute of Fundamental Research in India and the Mechanobiology Institute in Singapore. Dr. Beckerle is also currently on the Board of Directors of the American Association for Cancer Research, the Coalition for Life Sciences and the Huntsman Corporation.
Dr. Beckerle held a Guggenheim Fellowship at the Curie Institute in Paris, received the Utah Governor’s Medal for Science and Technology in 2001, the Sword of Hope Award from the American Cancer Society in 2004 and is an elected Fellow of the American Academy of Arts and Sciences.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field.
The Company has more than 265 operating companies conducting business around the world.
The Company’s primary focus is products related to human health and well-being.
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space.
The Company’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
You are viewing a republication of Market Daily News content. You can find full Market Daily News articles on (www.marketdailynews.com)
- Michael Kvitko Executive Vice President and Chief Merchandising Officer Of 99 Cents Only Stores LLC (NYSE:NDN) Resignes
- Marc Stolzman Departs Position As Zulily Inc (NASDAQ:ZU) CFO
- Richard W. Dreiling CEO Of Dollar General Corp. agrees to remain with the company until January, Adjusts Salary To Almost $1.4M
- The Gap Inc. Election Of Directors Voting Results
Source: http://marketdailynews.com/2015/06/10/johnson-johnson-appoints-new-director/
